BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 24556869)

  • 1. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.
    May MT; Gompels M; Delpech V; Porter K; Orkin C; Kegg S; Hay P; Johnson M; Palfreeman A; Gilson R; Chadwick D; Martin F; Hill T; Walsh J; Post F; Fisher M; Ainsworth J; Jose S; Leen C; Nelson M; Anderson J; Sabin C;
    AIDS; 2014 May; 28(8):1193-202. PubMed ID: 24556869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression.
    O'Connor JL; Smith CJ; Lampe FC; Hill T; Gompels M; Hay P; Chadwick D; Fisher M; Ainsworth J; Gilson R; Mackie N; Anderson J; Orkin C; Nelson M; Kegg S; Leen C; Palfreeman A; Post F; Johnson M; Sabin CA; Phillips AN;
    AIDS; 2014 Mar; 28(6):919-24. PubMed ID: 24335482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
    Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
    Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.
    Antiretroviral Therapy Cohort Collaboration
    Lancet HIV; 2017 Aug; 4(8):e349-e356. PubMed ID: 28501495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
    Ledergerber B; Lundgren JD; Walker AS; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; Gill MJ; Castelli F; Phillips AN;
    Lancet; 2004 Jul 3-9; 364(9428):51-62. PubMed ID: 15234856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
    Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
    AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies.
    Trickey A; Sabin CA; Burkholder G; Crane H; d'Arminio Monforte A; Egger M; Gill MJ; Grabar S; Guest JL; Jarrin I; Lampe FC; Obel N; Reyes JM; Stephan C; Sterling TR; Teira R; Touloumi G; Wasmuth JC; Wit F; Wittkop L; Zangerle R; Silverberg MJ; Justice A; Sterne JAC
    Lancet HIV; 2023 May; 10(5):e295-e307. PubMed ID: 36958365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.
    May M; Gompels M; Delpech V; Porter K; Post F; Johnson M; Dunn D; Palfreeman A; Gilson R; Gazzard B; Hill T; Walsh J; Fisher M; Orkin C; Ainsworth J; Bansi L; Phillips A; Leen C; Nelson M; Anderson J; Sabin C
    BMJ; 2011 Oct; 343():d6016. PubMed ID: 21990260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.
    Calkins KL; Lesko CR; Chander G; Moore RD; Lau B
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):317-324. PubMed ID: 29210833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based data.
    Kufa T; Shubber Z; MacLeod W; Takuva S; Carmona S; Bor J; Gorgens M; Pillay Y; Puren A; Eaton JW; Fraser-Hurt N
    PLoS One; 2019; 14(5):e0217742. PubMed ID: 31150489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study.
    O'Connor J; Smith C; Lampe FC; Johnson MA; Chadwick DR; Nelson M; Dunn D; Winston A; Post FA; Sabin C; Phillips AN;
    Lancet HIV; 2017 Jul; 4(7):e295-e302. PubMed ID: 28479492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.
    Sewell J; Daskalopoulou M; Nakagawa F; Lampe FC; Edwards S; Perry N; Wilkins E; O'Connell R; Jones M; Collins S; Speakman A; Phillips AN; Rodger AJ;
    HIV Med; 2017 Aug; 18(7):463-473. PubMed ID: 28004523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.
    ; Zwahlen M; Harris R; May M; Hogg R; Costagliola D; de Wolf F; Gill J; Fätkenheuer G; Lewden C; Saag M; Staszewski S; d'Arminio Monforte A; Casabona J; Lampe F; Justice A; von Wyl V; Egger M
    Int J Epidemiol; 2009 Dec; 38(6):1624-33. PubMed ID: 19820106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource-limited setting.
    Brennan AT; Maskew M; Sanne I; Fox MP
    Trop Med Int Health; 2013 May; 18(5):619-31. PubMed ID: 23419157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.
    May MT; Vehreschild JJ; Trickey A; Obel N; Reiss P; Bonnet F; Mary-Krause M; Samji H; Cavassini M; Gill MJ; Shepherd LC; Crane HM; d'Arminio Monforte A; Burkholder GA; Johnson MM; Sobrino-Vegas P; Domingo P; Zangerle R; Justice AC; Sterling TR; Miró JM; Sterne JAC; ; Boulle A; Stephan C; Miro JM; Cavassini M; Chêne G; Costagliola D; Dabis F; Monforte AD; Del Amo J; Van Sighem A; Fätkenheuer G; Gill J; Guest J; Haerry DH; Hogg R; Justice A; Shepherd L; Obel N; Crane H; Smith C; Reiss P; Saag M; Sterling T; Teira R; Williams M; Zangerle R; Sterne J; May M; Ingle S; Trickey A
    Clin Infect Dis; 2016 Jun; 62(12):1571-1577. PubMed ID: 27025828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.
    Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y
    Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.
    Johnson LF; Mossong J; Dorrington RE; Schomaker M; Hoffmann CJ; Keiser O; Fox MP; Wood R; Prozesky H; Giddy J; Garone DB; Cornell M; Egger M; Boulle A;
    PLoS Med; 2013; 10(4):e1001418. PubMed ID: 23585736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
    Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.
    Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S;
    HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda.
    Jain V; Byonanebye DM; Amanyire G; Kwarisiima D; Black D; Kabami J; Chamie G; Clark TD; Rooney JF; Charlebois ED; Kamya MR; Havlir DV;
    AIDS; 2014 Sep; 28(15):2241-9. PubMed ID: 25022596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.